US2002082424A1PendingUtilityA1
Synthesis of CC-1065/duocarmycin analogs
Est. expiryDec 8, 2017(expired)· nominal 20-yr term from priority
Inventors:Dale L. Boger
C07D 215/54C07C 271/28C07D 487/04C07D 209/08C07D 471/04
46
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The dihydroindole C-ring found in CC-1065/duocarmycin analogs is formed by the 5-exo-trig radical cyclization of an aryl halide onto a tethered vinyl chloride forming with chlorine installed as a suitable leaving group for subsequent cyclopropane spirocyclization. The versatility of this approach is disclosed in the context of six CC-1065/duocarmycin analogs previously synthesized in this laboratory.
Claims
exact text as granted — not AI-modifiedWhat is claimed:
1 . A method for the synthesis of a dihydroindole C-ring of a CC-1065/duocarmycin analog wherein the method comprises the steps of:
Step A: alkylating an aryl halide with 1,3-dichloropropene and a catalytic amount of n-tetrabutylammonium iodide for forming a vinyl chloride; then Step B: cyclizing the vinyl chloride of said step A under conditions using tribuytyl tin hydride, catalytic AIBN and toluene as the solvent for forming the dihydroindole C-ring of the CC-1065/duocarmycin analog.
2 . A compound represented by the following structure:
3 . A compound represented by the following structure:
4 . A compound represented by the following structure:
5 . A compound represented by the following structure:
6 . A compound represented by the following structure:
7 . A compound represented by the following structure:
8 . A compound represented by the following structure:
9 . A compound represented by the following structure:
10 . A compound represented by the following structure:
11 . A compound represented by the following structure:
12 . A compound represented by the following structure:
13 . A compound represented by the following structure:
14 . A compound represented by the following structure:
15 . A compound represented by the following structure:
16 . A compound represented by the following structure:
17 . A compound represented by the following structure:
18 . A compound represented by the following structure:Join the waitlist — get patent alerts
Track US2002082424A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.